| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Department of Measles Virus, National Institute of Health, Musashimurayama, Tokyo 208 [T.M.], and Third Department of Internal Medicine, Nihon University, Tokyo 173 [I.G.], Japan
Glutamine synthetase and glutaminase activities in human cirrhotic liver tissues and hepatocellular carcinomas were determined for comparison with normal liver tissues. In hepatocellular carcinoma, glutamine synthetase activity was approximately one-third of that in normal liver, whereas no detectable change in the enzyme activity was observed in cirrhotic liver. Phosphate-dependent and phosphate-independent glutaminase activities were increased approximately 20-fold and 6-fold, respectively, both in the carcinoma and cirrhotic liver compared with those from normal liver, Oxypolarographic tests showed that the rate of glutamine oxidation in the tumor and cirrhotic liver mitochondria was about 5-fold higher than that in the liver mitochondria. The rate of glutamate oxidation in the liver mitochondria was comparable to that in the cirrhotic liver and tumor mitochondria. Glutamine oxidation was inhibited by prior incubation of the mitochondria with 6-diazo-5-oxo-L-norleucine, which inhibited mitochondrial glutaminase. These results indicate that the product of glutamine hydrolysis, glutamate, is catabolized in the tumor and cirrhotic liver mitochondria to supply ATP.
In the liver and cirrhotic liver mitochondria, glutamate was oxidized via the routes of transamination and deamination. On the other hand, glutamate oxidation was initiated preferentially via a transamination pathway in the tumor mitochondria.
1 To whom requests for reprints should be addressed, at Department of Measles Virus, National Institute of Health, Gakuen, Musashimurayama, Tokyo 208.
Received 8/14/91. Accepted 12/13/91.
This article has been cited by other articles:
![]() |
B. C. Fuchs, J. C. Perez, J. E. Suetterlin, S. B. Chaudhry, and B. P. Bode Inducible antisense RNA targeting amino acid transporter ATB0/ASCT2 elicits apoptosis in human hepatoma cells Am J Physiol Gastrointest Liver Physiol, March 1, 2004; 286(3): G467 - G478. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. P. Bode, B. C. Fuchs, B. P. Hurley, J. L. Conroy, J. E. Suetterlin, K. K. Tanabe, D. B. Rhoads, S. F. Abcouwer, and W. W. Souba Molecular and functional analysis of glutamine uptake in human hepatoma and liver-derived cells Am J Physiol Gastrointest Liver Physiol, November 1, 2002; 283(5): G1062 - G1073. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. Goossens, J. Grooten, and W. Fiers The Oxidative Metabolism of Glutamine J. Biol. Chem., January 5, 1996; 271(1): 192 - 196. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cancer Prevention Research |
| Cancer Prevention Journals Portal | Cancer Reviews Online |
| Annual Meeting Education Book | Meeting Abstracts Online |